Table 3.
Clinicopathological characteristics of patients with or without pretreatment
| Characteristics | With pretreatment (n = 49) | Without pretreatment (n = 7) | p value |
|---|---|---|---|
| Age, years | 55 (22–69) | 55 (30–64) | 0.98 |
| Sex (male/female) | 37/12 | 6/1 | 0.55 |
| Etiology | 0.88 | ||
| Viral hepatitis C | 25 | 3 | |
| Viral hepatitis B | 15 | 3 | |
| Viral hepatitis C/B | 2 | 0 | |
| Others | 7 | 1 | |
| AFP, ng/mL | 93.9 (2–212,220) | 107 (23.8–2,093) | 0.68 |
| DCP, mAU/mL | 100 (2–20,600) | 107 (12–9,470) | 0.56 |
| Child-Pugh (A/B/C) | 24/25/0 | 0/7/0 | 0.01 |
| MELD | 10 (4–22) | 13 (10–16) | 0.28 |
| Maximum tumor size, cm | 3.3 (1–26) | 4.8 (3–7) | 0.62 |
| Tumors, n | 6 (2–186) | 3 (2–4) | 0.29 |
| Classification (well/mod./poor) | 3/32/14 | 1/6/0 | 0.23 |
| Microvascular invasion | 28 (57%) | 3 (43%) | 0.11 |
| Milan criteria met | 0 (0%) | 0 (0%) | - |
| Kyoto criteria met | 31 (63%) | 4 (57%) | 0.76 |
AFP, α-fetoprotein; DCP, des-gamma-carboxy prothrombin; MELD, model for end-stage liver disease.